Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with poor prognosis and no curative therapies. SCF-Skp2 E3 ligase is a target for cancer therapy, but there have been no reports about Skp2 as a target for IPF. Here we demonstrate that Skp2 is a promising therapeutic target for IPF. We ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikamo, Masashi, Kitagawa, Kyoko, Sakai, Satoshi, Uchida, Chiharu, Ohhata, Tatsuya, Nishimoto, Koji, Niida, Hiroyuki, Suzuki, Sayuri, Nakayama, Keiichi I., Inui, Naoki, Suda, Takafumi, Kitagawa, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855696/
https://www.ncbi.nlm.nih.gov/pubmed/29415439
http://dx.doi.org/10.3390/ijms19020474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855696/
https://www.ncbi.nlm.nih.gov/pubmed/29415439
http://dx.doi.org/10.3390/ijms19020474

Ejemplares similares